Kromek’s interim trading statement reflects the ongoing positive trajectory of last month’s full-year results, with the company expecting to report 1H26 revenues of at least £14.5m (1H25: £3.7m), including revenues derived from the Siemens Healthineers enablement agreement of at least £8.2m (1H25: nil). On this basis, underlying revenues for the period of at least £6.3m (1H25: £3.7m) indicate first-half underlying revenue growth of 70%, with the company also looking to report positive adjusted E ....
27 Oct 2025
Kromek - 1H26 trading statement, in-line with full-year expectations
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
Kromek - 1H26 trading statement, in-line with full-year expectations
Kromek Group Plc (KMK:LON) | 6.9 0 0.0% | Mkt Cap: 45.2m
- Published:
27 Oct 2025 -
Author:
Adam McCarter | Mike Mitchell -
Pages:
4 -
Kromek’s interim trading statement reflects the ongoing positive trajectory of last month’s full-year results, with the company expecting to report 1H26 revenues of at least £14.5m (1H25: £3.7m), including revenues derived from the Siemens Healthineers enablement agreement of at least £8.2m (1H25: nil). On this basis, underlying revenues for the period of at least £6.3m (1H25: £3.7m) indicate first-half underlying revenue growth of 70%, with the company also looking to report positive adjusted E ....